This video presents a collection of dermatopathology cases, simulating a typical daily sign-out of skin biopsies under the microscope. The speaker meticulously details the microscopic features of various benign and malignant skin lesions, including seborrheic keratoses, neurofibromas, pilomatricomas, Grover's disease, trichilemmomas, fibrous papules, nevi, squamous cell carcinomas, and arthropod bite reactions. A strong emphasis is placed on diagnostic criteria, key differentiators from look-alike lesions (e.g., distinguishing seborrheic keratosis from squamous cell carcinoma or melanoma, neurofibroma from DFSP), and clinically relevant associations such as Cowden syndrome or tuberous sclerosis. The video serves as a practical guide for identifying and understanding common and sometimes challenging skin pathologies.
Dermatopathology Case Review: Microscopic Diagnosis of Skin Biopsies
Clinical: Common in older individuals, appearing "stuck on" and often dark.
Microscopic Features: Characterized by epidermal thickening (acanthotic pattern), elongated rete ridges, and distinctive "horn pseudocysts" (pockets of loose keratin). Cells are typically small, uniform basaloid keratinocytes with melanin pigment transferred from melanocytes.
Key Takeaways: Look for exophytic growth (above skin surface) and a straight line across the lesion's bottom edge. Can be irritated and inflamed, potentially mimicking squamous cell carcinoma (SCC) clinically. Differentiate from melanoma by uniform cells and the presence of a nucleus in keratinocytes.
Clinical: A soft, dome-shaped, skin-colored lesion.
Microscopic Features: Composed of bland, elongated "spindle cells" (Schwann cells) with buckled or curved nuclei, embedded in a pale, loose collagenous or myxoid (hyaluronic acid) background. Small nerve twigs and scattered "fried egg" shaped mast cells are characteristic.
Key Takeaways: Mast cells are a useful clue. Must differentiate from Dermatofibrosarcoma Protuberans (DFSP), which can look similar but differs in immunohistochemical staining (DFSP is CD34+, Neurofibroma is S100/SOX10+).
Clinical: A hard, firm nodule, often calcified, which can clinically resemble a foreign body.
Microscopic Features: Features blue basaloid "matrical cells" (resembling hair follicle root cells) transitioning into anucleated, bright pink "ghost" or "shadow cells" (dead keratinocytes). Mitotic activity can be brisk but is usually benign.
Key Takeaways: The combination of basaloid cells and ghost cells is diagnostic. Often found in older adults and can be associated with sun-damaged skin (solar elastosis).
Clinical: Presents as itchy papules or bumps on the trunk, particularly in older patients.
Microscopic Features: Defined by "acantholysis" (keratinocytes losing contact and rounding up) and "dyskeratosis" (keratinocytes undergoing cell death, appearing bright pink with dense nuclei, often called "grains" or "Corps ronds"). Dermal inflammation with eosinophils is common.
Key Takeaways: Acantholysis and dyskeratosis on the trunk are highly suggestive. Differentiate from other acantholytic disorders like Pemphigus or Darier's disease by clinical context and pattern.
Clinical: Can present as a cutaneous horn or a wart-like lesion, often on the face, and may be clinically mistaken for basal cell carcinoma (BCC).
Microscopic Features: Exhibits exophytic growth and papillomatosis. Key features include a pushing border into the dermis, composed of clear/pale glycogenated cells often arranged in a palisading pattern. It's considered to involve the hair follicle.
Key Takeaways: Associated with Cowden syndrome (PTEN gene mutation), which carries an increased risk of internal cancers.
Clinical: Often appears as a pearly bump on the nose, commonly misdiagnosed as BCC.
Microscopic Features: Characterized by lichenification (thickened epidermis due to chronic rubbing), dense fibrous collagen in the dermis, dilated branching blood vessels, and stellate (star-shaped) or spindle-shaped fibroblasts.
Key Takeaways: Use the absence of normal solar elastosis as a diagnostic clue. Multiple fibrous papules in a younger patient (especially on the face) can be a sign of Tuberous Sclerosis.
Clinical: Raised, flesh-colored lesion, often on the scalp.
Microscopic Features: Shows nests of melanocytes in the dermis, often unpigmented. A crucial feature is "maturation," where melanocytes become smaller and more spindle-shaped as they go deeper into the dermis. Can feature multinucleated giant melanocytes and nuclear pseudo-inclusions. Congenital nevi often infiltrate deep, surrounding normal skin structures.
Key Takeaways: Look for maturation to distinguish from melanoma. Neurotized nevi can mimic neurofibromas deeply; finding melanocyte nests elsewhere confirms nevus.
Clinical: Often seen on sun-damaged skin, presenting as a crater-shaped lesion with keratin, clinically resembling a keratoacanthoma or other benign growths.
Microscopic Features: Characterized by atypical keratinocytes with dense, "glassy" eosinophilic cytoplasm and desmosome spines. The most critical feature is invasive, trickling growth into the dermis. Keratin pearls (balls of keratin with retained nuclei) are a classic finding. Parakeratosis within invasive nests is a strong indicator.
Key Takeaways: Invasion is key for diagnosis. Differentiate from irritated benign lesions by subtle nuclear atypia, glassy cytoplasm, and invasive patterns. Prognosis is generally good if treated when small, though SCCs on the ear or lip have a higher risk of metastasis.
Clinical: Presents as an ulcer or crusted lesion, which can clinically mimic skin cancer, especially if chronically picked at or secondarily infected. Patients may not recall a bite.
Microscopic Features: Marked by scale crust (ulceration) with neutrophils and bacteria, but the defining feature is a dense "eosinophilic" infiltrate (many eosinophils) around superficial and deep vessels, extending into the collagen.
Key Takeaways: The presence of abundant eosinophils is a crucial diagnostic clue. Exuberant bug bite reactions are common in young children and, for unclear reasons, in patients with Chronic Lymphocytic Leukemia (CLL).